BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Drent M, Strookappe B, Hoitsma E, De Vries J. Consequences of Sarcoidosis. Clinics in Chest Medicine 2015;36:727-37. [DOI: 10.1016/j.ccm.2015.08.013] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Hoth KF, Simmering J, Croghan A, Hamzeh NY. Cognitive Difficulties and Health-Related Quality of Life in Sarcoidosis: An Analysis of the GRADS Cohort. JCM 2022;11:3594. [DOI: 10.3390/jcm11133594] [Reference Citation Analysis]
2 Jamilloux Y, El Jammal T, Bert A, Sève P. [Hydroxychloroquine for non-severe extra-pulmonary sarcoidosis]. Rev Med Interne 2022:S0248-8663(22)00453-2. [PMID: 35660263 DOI: 10.1016/j.revmed.2022.04.030] [Reference Citation Analysis]
3 Pescaru C, Frandes M, Marc M, Traila D, Pescaru A, Oancea C. Physical Activity and Respiratory Muscle Strength in Patients with Sarcoidosis: An Observational Study. Int J Gen Med 2022;15:291-7. [PMID: 35023966 DOI: 10.2147/IJGM.S334019] [Reference Citation Analysis]
4 Drent M, Costabel U, Crouser ED, Grunewald J, Bonella F. Misconceptions regarding symptoms of sarcoidosis. Lancet Respir Med 2021;9:816-8. [PMID: 34216548 DOI: 10.1016/S2213-2600(21)00311-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Sharp M, Eakin MN, Drent M. Socioeconomic determinants and disparities in sarcoidosis. Curr Opin Pulm Med 2020;26:568-73. [PMID: 32732595 DOI: 10.1097/MCP.0000000000000704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J, Rivera F, Howie M, Reese R, Goodman M, Hart P, Strookappe B, De Vries J, Rosenbach M, Scholand MB, Lammi MR, Elfferich M, Lower E, Baughman RP, Sweiss N, Judson MA, Drent M. Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics (Basel) 2021;11:1089. [PMID: 34203584 DOI: 10.3390/diagnostics11061089] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Sève P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S, Boussel L, Calender A, Androdias G, Valeyre D, El Jammal T. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis. Cells 2021;10:766. [PMID: 33807303 DOI: 10.3390/cells10040766] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
8 Alfaro TM, Wijsenbeek MS, Powell P, Stolz D, Hurst JR, Kreuter M, Moor CC. Educational aspects of rare and orphan lung diseases. Respir Res 2021;22:92. [PMID: 33761959 DOI: 10.1186/s12931-021-01676-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Etinger R, Comaneshter D, Amital H, Cohen AD, Tiosano S. The long-term prognostic significance of heart failure in sarcoidosis patients ─ a cohort study. Postgrad Med 2021;133:202-8. [PMID: 33019840 DOI: 10.1080/00325481.2020.1832773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Kahlmann V, Janssen Bonás M, Moor CC, van Moorsel CHM, Kool M, Kraaijvanger R, Grutters JC, Overgaauw M, Veltkamp M, Wijsenbeek MS; Collaborating investigators. Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study. BMC Pulm Med 2020;20:271. [PMID: 33076885 DOI: 10.1186/s12890-020-01290-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
11 Drent M, Elfferich M, Breedveld E, Vries J, Strookappe B. Benefit of Wearing an Activity Tracker in Sarcoidosis. J Pers Med 2020;10:E97. [PMID: 32842583 DOI: 10.3390/jpm10030097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Voortman M, Stern BJ, Saketkoo LA, Drent M. The Burden of Neurosarcoidosis: Essential Approaches to Early Diagnosis and Treatment. Semin Respir Crit Care Med 2020;41:641-51. [PMID: 32777849 DOI: 10.1055/s-0040-1710576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Castro MDC, Pereira CAC. Nonlife-Threatening Sarcoidosis. Semin Respir Crit Care Med 2020;41:733-40. [PMID: 32777854 DOI: 10.1055/s-0040-1710371] [Reference Citation Analysis]
14 Obi ON. Health-Related Quality of Life in Sarcoidosis. Semin Respir Crit Care Med 2020;41:716-32. [PMID: 32583381 DOI: 10.1055/s-0040-1710080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
15 van Helmondt SJ, Polish LB, Judson MA, Grutters JC. Patient perspectives in sarcoidosis. Curr Opin Pulm Med 2019;25:478-83. [PMID: 31365382 DOI: 10.1097/MCP.0000000000000602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
16 Tavee J, Culver D. Nonorgan manifestations of sarcoidosis. Curr Opin Pulm Med 2019;25:533-8. [PMID: 31365388 DOI: 10.1097/MCP.0000000000000597] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Kahlmann V, Moor CC, Wijsenbeek MS. Managing Fatigue in Patients With Interstitial Lung Disease. Chest 2020;158:2026-33. [PMID: 32387518 DOI: 10.1016/j.chest.2020.04.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Voortman M, Beekman E, Drent M, Hoitsma E, De Vries J. Determination of the smallest detectable change (SDC) and the minimal important difference (MID) for the Small Fiber Neuropathy Screening List (SFNSL) in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2018;35:333-41. [PMID: 32476921 DOI: 10.36141/svdld.v35i4.7260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Voortman M, Drent M, Baughman RP. Management of neurosarcoidosis: a clinical challenge. Curr Opin Neurol 2019;32:475-83. [PMID: 30865007 DOI: 10.1097/WCO.0000000000000684] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
20 Moor CC, Kahlmann V, Culver DA, Wijsenbeek MS. Comprehensive Care for Patients with Sarcoidosis. J Clin Med 2020;9:E390. [PMID: 32024123 DOI: 10.3390/jcm9020390] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
21 James WE, Judson MA. Therapeutic strategies for pulmonary sarcoidosis. Expert Rev Respir Med 2020;14:391-403. [PMID: 32003264 DOI: 10.1080/17476348.2020.1721284] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Drent M, Proesmans VLJ, Elfferich MDP, Jessurun NT, de Jong SMG, Ebner NM, Lewis EDO, Bast A. Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis. Lung 2020;198:395-403. [PMID: 31960165 DOI: 10.1007/s00408-020-00323-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
23 Voortman M, Hendriks CMR, Lodder P, Drent M, De Vries J. Quality of Life of Couples Living with Sarcoidosis. Respiration 2019;98:373-82. [PMID: 31437834 DOI: 10.1159/000501657] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J. Sarcoidosis. Nat Rev Dis Primers 2019;5:45. [PMID: 31273209 DOI: 10.1038/s41572-019-0096-x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 123] [Article Influence: 30.3] [Reference Citation Analysis]
25 Hendriks C, Drent M, Elfferich M, De Vries J. The Fatigue Assessment Scale: quality and availability in sarcoidosis and other diseases. Curr Opin Pulm Med. 2018;24:495-503. [PMID: 29889115 DOI: 10.1097/mcp.0000000000000496] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
26 Cozier YC, Govender P, Berman JS. Obesity and sarcoidosis: consequence or contributor? Curr Opin Pulm Med 2018;24:487-94. [PMID: 29979212 DOI: 10.1097/MCP.0000000000000503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kouranos V, Wells A, Walsh S. Why do people die from pulmonary sarcoidosis? Curr Opin Pulm Med 2018;24:527-35. [PMID: 30004991 DOI: 10.1097/MCP.0000000000000499] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Hendriks CMR, Saketkoo LA, Elfferich MDP, De Vries J, Wijnen PAHM, Drent M. Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability. Lung 2019;197:407-13. [PMID: 31101981 DOI: 10.1007/s00408-019-00234-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
29 Gwathmey KG, Pearson KT. Diagnosis and management of sensory polyneuropathy. BMJ 2019;365:l1108. [PMID: 31068323 DOI: 10.1136/bmj.l1108] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
30 Moor CC, Gür-Demirel Y, Wijsenbeek MS. Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis. J Pers Med 2019;9:E23. [PMID: 31060343 DOI: 10.3390/jpm9020023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
31 Voortman M, De Vries J, Hendriks CMR, Elfferich MDP, Wijnen PAHM, Drent M. Everyday cognitive failure in patients suffering from neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2019;36:2-10. [PMID: 32476930 DOI: 10.36141/svdld.v36i1.7412] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
32 Gade Sikjær M, Hilberg O, Ibsen R, Bock K, Løkke A. Direct and indirect economic and health consequences related to sarcoidosis in Denmark: A national register-based study. Respir Med 2019;152:7-13. [PMID: 31128613 DOI: 10.1016/j.rmed.2019.04.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
33 Voortman M, Hendriks CMR, Elfferich MDP, Bonella F, Møller J, De Vries J, Costabel U, Drent M. The Burden of Sarcoidosis Symptoms from a Patient Perspective. Lung 2019;197:155-61. [PMID: 30778661 DOI: 10.1007/s00408-019-00206-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
34 Baughman RP, Barriuso R, Beyer K, Boyd J, Hochreiter J, Knoet C, Martone F, Quadder B, Richardson J, Spitzer G, Valeyre D, Ziosi G. Sarcoidosis: patient treatment priorities. ERJ Open Res 2018;4:00141-2018. [PMID: 30588477 DOI: 10.1183/23120541.00141-2018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
35 Min M, Shi T, Sun C, Liang M, Zhang Y, Wu Y, Sun Y. The association between orthostatic hypotension and dementia: A meta-analysis of prospective cohort studies. Int J Geriatr Psychiatry 2018;33:1541-7. [DOI: 10.1002/gps.4964] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
36 Moor CC, van Manen MJG, van Hagen PM, Miedema JR, van den Toorn LM, Gür-Demirel Y, Berendse APC, van Laar JAM, Wijsenbeek MS. Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners. Lung 2018;196:569-75. [PMID: 30088094 DOI: 10.1007/s00408-018-0144-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
37 Korsten P, Drent M. Multisystemic manifestations of sarcoidosis and comorbidities. Curr Opin Pulm Med 2018;24:477-8. [PMID: 30004993 DOI: 10.1097/MCP.0000000000000505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Saketkoo LA, Karpinski A, Young J, Adell R, Walker M, Hennebury T, Wickremasinghe M, Russell AM. Feasibility, utility and symptom impact of modified mindfulness training in sarcoidosis. ERJ Open Res 2018;4:00085-2017. [PMID: 29750143 DOI: 10.1183/23120541.00085-2017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
39 Hendriks C, Drent M, De Kleijn W, Elfferich M, Wijnen P, De Vries J. Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: A prospective follow-up study. Respiratory Medicine 2018;138:S24-30. [DOI: 10.1016/j.rmed.2017.11.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
40 Bahmer T, Watz H, Develaska M, Waschki B, Rabe KF, Magnussen H, Kirsten D, Kirsten AM. Physical Activity and Fatigue in Patients with Sarcoidosis. Respiration 2018;95:18-26. [PMID: 29131111 DOI: 10.1159/000481827] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
41 Oudejans LC, Niesters M, Brines M, Dahan A, van Velzen M. Quantification of small fiber pathology in patients with sarcoidosis and chronic pain using cornea confocal microscopy and skin biopsies. J Pain Res 2017;10:2057-65. [PMID: 28894389 DOI: 10.2147/JPR.S142683] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
42 Mañá J, Rubio-Rivas M, Villalba N, Marcoval J, Iriarte A, Molina-Molina M, Llatjos R, García O, Martínez-Yélamos S, Vicens-Zygmunt V, Gámez C, Pujol R, Corbella X. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain. Medicine (Baltimore) 2017;96:e7595. [PMID: 28723801 DOI: 10.1097/MD.0000000000007595] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
43 Strookappe B, Saketkoo LA, Elfferich M, Holland A, De Vries J, Knevel T, Drent M. Physical activity and training in sarcoidosis: review and experience-based recommendations. Expert Rev Respir Med 2016;10:1057-68. [PMID: 27552344 DOI: 10.1080/17476348.2016.1227244] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
44 Strookappe B, De Vries J, Elfferich M, Kuijpers P, Knevel T, Drent M. Predictors of fatigue in sarcoidosis: The value of exercise testing. Respiratory Medicine 2016;116:49-54. [DOI: 10.1016/j.rmed.2016.05.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
45 Jeny F, Bouvry D, Freynet O, Soussan M, Brauner M, Planes C, Nunes H, Valeyre D. Management of sarcoidosis in clinical practice. Eur Respir Rev 2016;25:141-50. [DOI: 10.1183/16000617.0013-2016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
46 Strookappe B, Swigris J, De Vries J, Elfferich M, Knevel T, Drent M. Benefits of Physical Training in Sarcoidosis. Lung 2015;193:701-8. [PMID: 26286208 DOI: 10.1007/s00408-015-9784-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]